ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500257 announcements Lupin Ltd. announcements and dividends declared BSE

Lupin Ltd. Complete list of announcements declared & dividend announcements by Lupin Ltd. 500257

Lupin Ltd. 500257 listed on BSE and deals in

Announcements and dividends declared by Lupin Ltd. 500257

Lupin gets USFDA nod for generic tablets to treat excessive daytime sleepiness
Pharma major Lupin Ltd announced receiving final USFDA approval for its generic Pitolisant tablets. These tablets are indicated for treating excessive daytime sleepiness in patients. The US health regulator approved strengths of 4.45 mg and 17.8 mg. Lup
Announcement as on 17 August 2026

Lupin receives USFDA approval for Sodium Zirconium Cyclosilicate for Oral Suspension
Lupin announced that it has received approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Sodium Zirconium Cyclosilicate for Oral Suspension, 5 g/packet and 10 g/packet.
Announcement as on 10 August 2026

Lupin Q1 PAT rises 16 pc at Rs 1,417 cr
Lupin Ltd has reported a remarkable sixteen percent surge in profit after tax for the first quarter, showcasing their continued success. The firm experienced considerable growth in consolidated total revenue from operations, largely driven by a staggering
Announcement as on 07 August 2026

Lupin launches generic Sugammadex injection in US
Lupin Limited announced the launch of its Sugammadex Injection in the United States. This follows approval from the US Food and Drug Administration for its abbreviated new drug application. The company's injection is claimed to be bioequivalent to Merck's
Announcement as on 31 July 2026

Lupin launches generic anti-diabetic tablets in US
Pharma major Lupin has launched its generic anti-diabetic medicine in the United States. The medicine is dapagliflozin and metformin hydrochloride extended-release tablets. The US Food and Drug Administration approved the drug. Lupin's product is bioequiva
Announcement as on 22 April 2026

Announcements by Lupin Ltd. first page | Next page | Prev page |

500257 Lupin Ltd. current price & indicator signals

Moving Averages for Lupin Ltd.

  • 5Day Average: 2145.32
  • 12Day Average: 2168.21
  • 20Day Average: 2201.82
  • 50Day Average: 2339.32
  • 100Day Average: 2319.74
  • 150Day Average: 2300.54
  • 200Day Average: 2251.84

500257 Indicators & signals

Indicator MACD (12,26,9)

2172.19, 2229.76, -54.46
Indicator MACD is in negative zone

Indicator ADX (14)

29.74, 13.86, 25.58
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500257 Lupin Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
04 Fri Sep 2026 2111.00 2104.40 to 2149.75 -1.12% 0.26 times
03 Thu Sep 2026 2135.00 2135.00 to 2170.00 -0.82% 1.84 times
02 Wed Sep 2026 2152.60 2136.10 to 2192.95 0.12% 3.19 times
01 Tue Sep 2026 2150.00 2140.00 to 2198.30 -1.29% 0.21 times
31 Mon Aug 2026 2178.00 2145.55 to 2209.00 0.14% 0.34 times
28 Fri Aug 2026 2175.00 2153.50 to 2179.50 0.48% 0.21 times
27 Thu Aug 2026 2164.60 2145.35 to 2187.45 -1.21% 0.66 times
26 Wed Aug 2026 2191.20 2175.00 to 2237.00 0.74% 0.41 times
25 Tue Aug 2026 2175.00 2159.40 to 2185.00 -0.68% 2.56 times
24 Mon Aug 2026 2190.00 2181.00 to 2224.50 -0.14% 0.16 times
21 Fri Aug 2026 2193.00 2186.85 to 2215.00 -0.46% 0.42 times
20 Thu Aug 2026 2203.10 2203.10 to 2243.05 -0.76% 0.1 times

Videos related to: 500257 announcements Lupin Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

500257 announcements Lupin Ltd. announcements and dividends declared BSE

 

Back to top